HEADER OXIDOREDUCTASE/OXIDOREDUCTASE INHIBITOR 22-OCT-12 4HOE TITLE CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH NADPH AND 5- TITLE 2 [3-(2,5-DIMETHOXY-4-PHENYLPHENYL)BUT-1-YN-1-YL]-6-METHYLPYRIMIDINE-2, TITLE 3 4-DIAMINE (UCP111E) COMPND MOL_ID: 1; COMPND 2 MOLECULE: DIHYDROFOLATE REDUCTASE; COMPND 3 CHAIN: A, B; COMPND 4 EC: 1.5.1.3; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CANDIDA ALBICANS; SOURCE 3 ORGANISM_COMMON: YEAST; SOURCE 4 ORGANISM_TAXID: 5476; SOURCE 5 GENE: DFR1, DHFR; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET41 KEYWDS ANTIFUNGAL AGENTS, CANDIDA ALBICANS, DRUG DESIGN, ENZYME INHIBITORS, KEYWDS 2 FUNGAL PROTEINS, STRUCTURE-ACTIVITY RELATIONSHIP, TETRAHYDROFOLATE KEYWDS 3 DEHYDROGENASE, OXIDOREDUCTASE-OXIDOREDUCTASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.L.PAULSEN,A.C.ANDERSON REVDAT 2 09-APR-14 4HOE 1 JRNL REVDAT 1 19-MAR-14 4HOE 0 JRNL AUTH N.G-DAYANANDAN,J.L.PAULSEN,K.VISWANATHAN,S.KESHIPEDDY, JRNL AUTH 2 M.N.LOMBARDO,W.ZHOU,K.M.LAMB,A.E.SOCHIA,J.B.ALVERSON, JRNL AUTH 3 N.D.PRIESTLEY,D.L.WRIGHT,A.C.ANDERSON JRNL TITL PROPARGYL-LINKED ANTIFOLATES ARE DUAL INHIBITORS OF CANDIDA JRNL TITL 2 ALBICANS AND CANDIDA GLABRATA. JRNL REF J.MED.CHEM. V. 57 2643 2014 JRNL REFN ISSN 0022-2623 JRNL PMID 24568657 JRNL DOI 10.1021/JM401916J REMARK 2 REMARK 2 RESOLUTION. 1.76 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.76 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.50 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.5 REMARK 3 NUMBER OF REFLECTIONS : 37070 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.183 REMARK 3 R VALUE (WORKING SET) : 0.181 REMARK 3 FREE R VALUE : 0.216 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1853 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3128 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 171 REMARK 3 SOLVENT ATOMS : 341 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 16.94 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.00000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : 0.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.137 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.125 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.075 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.284 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN USED IF PRESENT IN REMARK 3 THE INPUT U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 4HOE COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 01-NOV-12. REMARK 100 THE RCSB ID CODE IS RCSB075718. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 26-JUN-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X4A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97916 REMARK 200 MONOCHROMATOR : SAGITALLY FOCUSED SI(111) REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 37088 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.760 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.1 REMARK 200 DATA REDUNDANCY : 3.700 REMARK 200 R MERGE (I) : 0.06300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 18.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.76 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.79 REMARK 200 COMPLETENESS FOR SHELL (%) : 87.4 REMARK 200 DATA REDUNDANCY IN SHELL : 3.60 REMARK 200 R MERGE FOR SHELL (I) : 0.20200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 1AOE REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.94 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.16 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 3350, KMES, GLYCINE, PH 6.5, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 33.26900 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 107 -74.29 -85.49 REMARK 500 LYS A 150 79.89 -116.12 REMARK 500 LYS B 150 64.33 -113.89 REMARK 500 REMARK 500 REMARK: NULL REMARK 650 REMARK 650 HELIX REMARK 650 DETERMINATION METHOD: AUTHOR DETERMINED REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NDP A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 18G A 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GLY A 203 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 204 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NDP B 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 18G B 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 203 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3QLR RELATED DB: PDB REMARK 900 CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH REMARK 900 NADPH AND 6-METHYL-5-[(3R)-3-(3,4,5-TRIMETHOXYPHENYL)PENT- REMARK 900 1-YN-1-YL]PYRIMIDINE-2,4-DIAMINE (UCP112A) REMARK 900 RELATED ID: 3QLS RELATED DB: PDB REMARK 900 CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH REMARK 900 NADPH AND 6-METHYL-5-[3-METHYL-3-(3,4,5-TRIMETHOXYPHENYL) REMARK 900 BUT-1-YN-1-YL]PYRIMIDINE-2,4-DIAMINE (UCP115A) REMARK 900 RELATED ID: 3QLW RELATED DB: PDB REMARK 900 CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH REMARK 900 NADPH AND 5-[3-(2,5-DIMETHOXYPHENYL)PROP-1-YN-1-YL]-6- REMARK 900 ETHYLPYRIMIDINE-2,4-DIAMINE (UCP120B) REMARK 900 RELATED ID: 4H95 RELATED DB: PDB REMARK 900 CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH REMARK 900 NADPH AND 6-ETHYL-5-{3-[3-METHOXY-5-(PYRIDIN-4-YL)PHENYL] REMARK 900 BUT-1-YN-1-YL}PYRIMIDINE-2,4-DIAMINE (UCP1006) REMARK 900 RELATED ID: 4H96 RELATED DB: PDB REMARK 900 CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH REMARK 900 NADPH AND 5-{3-[3-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-5- REMARK 900 METHOXYPHENYL]PROP-1-YN-1-YL}-6-ETHYLPYRIMIDINE-2,4-DIAMINE REMARK 900 (UCP1018) REMARK 900 RELATED ID: 4H97 RELATED DB: PDB REMARK 900 CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH REMARK 900 NADPH AND 5-{3-[3-METHOXY-5-(4-METHYLPHENYL)PHENYL]BUT-1-YN REMARK 900 -1-YL}-6-METHYLPYRIMIDINE-2,4-DIAMINE (UCP111D4M) REMARK 900 RELATED ID: 4H98 RELATED DB: PDB REMARK 900 CANDIDA GLABRATA DIHYDROFOLATE REDUCTASE COMPLEXED WITH REMARK 900 NADPH AND 5-{3-[3-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-5- REMARK 900 METHOXYPHENYL]PROP-1-YN-1-YL}-6-ETHYLPYRIMIDINE-2,4-DIAMINE REMARK 900 (UCP1018) REMARK 900 RELATED ID: 4HOF RELATED DB: PDB REMARK 900 CANDIDA ALBICANS DIHYDROFOLATE REDUCTASE COMPLEXED WITH REMARK 900 NADPH AND 5-[3-(2-METHOXY-4-PHENYLPHENYL)BUT-1-YN-1-YL]-6- REMARK 900 METHYLPYRIMIDINE-2,4-DIAMINE REMARK 900 RELATED ID: 4HOG RELATED DB: PDB REMARK 900 CANDIDA GLABRATA DIHYDROFOLATE REDUCTASE COMPLEXED WITH REMARK 900 NADPH AND 5-[3-(2-METHOXY-4-PHENYLPHENYL)BUT-1-YN-1-YL]-6- REMARK 900 METHYLPYRIMIDINE-2,4-DIAMINE (UCP111H) DBREF 4HOE A 1 192 UNP P22906 DYR_CANAX 1 192 DBREF 4HOE B 1 192 UNP P22906 DYR_CANAX 1 192 SEQADV 4HOE LEU A 2 UNP P22906 SER 2 VARIANT SEQADV 4HOE GLU A 84 UNP P22906 LYS 84 VARIANT SEQADV 4HOE LEU B 2 UNP P22906 SER 2 VARIANT SEQADV 4HOE GLU B 84 UNP P22906 LYS 84 VARIANT SEQRES 1 A 192 MET LEU LYS PRO ASN VAL ALA ILE ILE VAL ALA ALA LEU SEQRES 2 A 192 LYS PRO ALA LEU GLY ILE GLY TYR LYS GLY LYS MET PRO SEQRES 3 A 192 TRP ARG LEU ARG LYS GLU ILE ARG TYR PHE LYS ASP VAL SEQRES 4 A 192 THR THR ARG THR THR LYS PRO ASN THR ARG ASN ALA VAL SEQRES 5 A 192 ILE MET GLY ARG LYS THR TRP GLU SER ILE PRO GLN LYS SEQRES 6 A 192 PHE ARG PRO LEU PRO ASP ARG LEU ASN ILE ILE LEU SER SEQRES 7 A 192 ARG SER TYR GLU ASN GLU ILE ILE ASP ASP ASN ILE ILE SEQRES 8 A 192 HIS ALA SER SER ILE GLU SER SER LEU ASN LEU VAL SER SEQRES 9 A 192 ASP VAL GLU ARG VAL PHE ILE ILE GLY GLY ALA GLU ILE SEQRES 10 A 192 TYR ASN GLU LEU ILE ASN ASN SER LEU VAL SER HIS LEU SEQRES 11 A 192 LEU ILE THR GLU ILE GLU HIS PRO SER PRO GLU SER ILE SEQRES 12 A 192 GLU MET ASP THR PHE LEU LYS PHE PRO LEU GLU SER TRP SEQRES 13 A 192 THR LYS GLN PRO LYS SER GLU LEU GLN LYS PHE VAL GLY SEQRES 14 A 192 ASP THR VAL LEU GLU ASP ASP ILE LYS GLU GLY ASP PHE SEQRES 15 A 192 THR TYR ASN TYR THR LEU TRP THR ARG LYS SEQRES 1 B 192 MET LEU LYS PRO ASN VAL ALA ILE ILE VAL ALA ALA LEU SEQRES 2 B 192 LYS PRO ALA LEU GLY ILE GLY TYR LYS GLY LYS MET PRO SEQRES 3 B 192 TRP ARG LEU ARG LYS GLU ILE ARG TYR PHE LYS ASP VAL SEQRES 4 B 192 THR THR ARG THR THR LYS PRO ASN THR ARG ASN ALA VAL SEQRES 5 B 192 ILE MET GLY ARG LYS THR TRP GLU SER ILE PRO GLN LYS SEQRES 6 B 192 PHE ARG PRO LEU PRO ASP ARG LEU ASN ILE ILE LEU SER SEQRES 7 B 192 ARG SER TYR GLU ASN GLU ILE ILE ASP ASP ASN ILE ILE SEQRES 8 B 192 HIS ALA SER SER ILE GLU SER SER LEU ASN LEU VAL SER SEQRES 9 B 192 ASP VAL GLU ARG VAL PHE ILE ILE GLY GLY ALA GLU ILE SEQRES 10 B 192 TYR ASN GLU LEU ILE ASN ASN SER LEU VAL SER HIS LEU SEQRES 11 B 192 LEU ILE THR GLU ILE GLU HIS PRO SER PRO GLU SER ILE SEQRES 12 B 192 GLU MET ASP THR PHE LEU LYS PHE PRO LEU GLU SER TRP SEQRES 13 B 192 THR LYS GLN PRO LYS SER GLU LEU GLN LYS PHE VAL GLY SEQRES 14 B 192 ASP THR VAL LEU GLU ASP ASP ILE LYS GLU GLY ASP PHE SEQRES 15 B 192 THR TYR ASN TYR THR LEU TRP THR ARG LYS HET NDP A 201 48 HET 18G A 202 29 HET GLY A 203 5 HET GOL A 204 6 HET NDP B 201 48 HET 18G B 202 29 HET GOL B 203 6 HETNAM NDP NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE HETNAM 2 NDP PHOSPHATE HETNAM 18G 5-[3-(2,5-DIMETHOXY-4-PHENYLPHENYL)BUT-1-YN-1-YL]-6- HETNAM 2 18G METHYLPYRIMIDINE-2,4-DIAMINE HETNAM GLY GLYCINE HETNAM GOL GLYCEROL HETSYN 18G 5-[(3S)-3-(2,5-DIMETHOXYBIPHENYL-4-YL)BUT-1-YN-1-YL]-6- HETSYN 2 18G METHYLPYRIMIDINE-2,4-DIAMINE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 NDP 2(C21 H30 N7 O17 P3) FORMUL 4 18G 2(C23 H24 N4 O2) FORMUL 5 GLY C2 H5 N O2 FORMUL 6 GOL 2(C3 H8 O3) FORMUL 10 HOH *341(H2 O) HELIX 1 1 LEU A 29 ARG A 42 1 14 HELIX 2 2 ARG A 56 GLU A 60 1 5 HELIX 3 4 SER A 95 LEU A 102 1 8 HELIX 4 5 GLY A 114 ILE A 122 1 9 HELIX 5 6 SER A 139 ILE A 143 5 5 HELIX 6 7 PRO A 152 GLU A 154 5 3 HELIX 7 8 PRO A 160 GLY A 169 1 10 HELIX 8 9 LEU B 29 ARG B 42 1 14 HELIX 9 10 ARG B 56 GLU B 60 1 5 HELIX 10 12 SER B 95 LEU B 100 1 6 HELIX 11 13 GLY B 114 ILE B 122 1 9 HELIX 12 14 SER B 139 ILE B 143 5 5 HELIX 13 15 PRO B 152 GLU B 154 5 3 HELIX 14 16 PRO B 160 GLY B 169 1 10 SHEET 1 A 9 GLU A 84 ASP A 87 0 SHEET 2 A 9 ILE A 90 ALA A 93 -1 O HIS A 92 N GLU A 84 SHEET 3 A 9 LEU A 73 LEU A 77 1 N ILE A 76 O ILE A 91 SHEET 4 A 9 ARG A 49 GLY A 55 1 N VAL A 52 O ILE A 75 SHEET 5 A 9 VAL A 106 GLY A 113 1 O PHE A 110 N ALA A 51 SHEET 6 A 9 VAL A 6 LEU A 13 1 N ALA A 7 O ILE A 111 SHEET 7 A 9 VAL A 127 GLU A 136 1 O LEU A 131 N ILE A 8 SHEET 8 A 9 PHE A 182 ARG A 191 -1 O THR A 183 N GLU A 136 SHEET 9 A 9 TRP A 156 LYS A 158 -1 N THR A 157 O THR A 190 SHEET 1 B 9 GLU A 84 ASP A 87 0 SHEET 2 B 9 ILE A 90 ALA A 93 -1 O HIS A 92 N GLU A 84 SHEET 3 B 9 LEU A 73 LEU A 77 1 N ILE A 76 O ILE A 91 SHEET 4 B 9 ARG A 49 GLY A 55 1 N VAL A 52 O ILE A 75 SHEET 5 B 9 VAL A 106 GLY A 113 1 O PHE A 110 N ALA A 51 SHEET 6 B 9 VAL A 6 LEU A 13 1 N ALA A 7 O ILE A 111 SHEET 7 B 9 VAL A 127 GLU A 136 1 O LEU A 131 N ILE A 8 SHEET 8 B 9 PHE A 182 ARG A 191 -1 O THR A 183 N GLU A 136 SHEET 9 B 9 ILE A 177 GLU A 179 -1 N GLU A 179 O PHE A 182 SHEET 1 C 2 GLY A 18 GLY A 20 0 SHEET 2 C 2 THR A 147 PHE A 148 -1 O THR A 147 N ILE A 19 SHEET 1 D 9 GLU B 84 ASP B 87 0 SHEET 2 D 9 ILE B 90 ALA B 93 -1 O HIS B 92 N GLU B 84 SHEET 3 D 9 LEU B 73 LEU B 77 1 N ILE B 76 O ALA B 93 SHEET 4 D 9 ALA B 51 GLY B 55 1 N VAL B 52 O LEU B 73 SHEET 5 D 9 ARG B 108 ILE B 111 1 O PHE B 110 N ILE B 53 SHEET 6 D 9 ASN B 5 LEU B 13 1 N ALA B 7 O ILE B 111 SHEET 7 D 9 VAL B 127 GLU B 136 1 O LEU B 131 N ILE B 8 SHEET 8 D 9 PHE B 182 ARG B 191 -1 O THR B 183 N GLU B 136 SHEET 9 D 9 TRP B 156 LYS B 158 -1 N THR B 157 O THR B 190 SHEET 1 E 9 GLU B 84 ASP B 87 0 SHEET 2 E 9 ILE B 90 ALA B 93 -1 O HIS B 92 N GLU B 84 SHEET 3 E 9 LEU B 73 LEU B 77 1 N ILE B 76 O ALA B 93 SHEET 4 E 9 ALA B 51 GLY B 55 1 N VAL B 52 O LEU B 73 SHEET 5 E 9 ARG B 108 ILE B 111 1 O PHE B 110 N ILE B 53 SHEET 6 E 9 ASN B 5 LEU B 13 1 N ALA B 7 O ILE B 111 SHEET 7 E 9 VAL B 127 GLU B 136 1 O LEU B 131 N ILE B 8 SHEET 8 E 9 PHE B 182 ARG B 191 -1 O THR B 183 N GLU B 136 SHEET 9 E 9 ILE B 177 GLU B 179 -1 N ILE B 177 O TYR B 184 SHEET 1 F 2 GLY B 18 GLY B 20 0 SHEET 2 F 2 THR B 147 PHE B 148 -1 O THR B 147 N ILE B 19 CISPEP 1 LYS A 14 PRO A 15 0 -2.45 CISPEP 2 ARG A 67 PRO A 68 0 -0.24 CISPEP 3 GLY A 113 GLY A 114 0 -1.23 CISPEP 4 LYS B 14 PRO B 15 0 -2.90 CISPEP 5 ARG B 67 PRO B 68 0 -0.63 CISPEP 6 GLY B 113 GLY B 114 0 -0.25 SITE 1 AC1 33 VAL A 10 ALA A 11 ILE A 19 GLY A 20 SITE 2 AC1 33 GLY A 23 LYS A 24 MET A 25 LYS A 31 SITE 3 AC1 33 GLY A 55 ARG A 56 LYS A 57 THR A 58 SITE 4 AC1 33 LEU A 77 SER A 78 ARG A 79 SER A 94 SITE 5 AC1 33 ILE A 112 GLY A 114 ALA A 115 GLU A 116 SITE 6 AC1 33 ILE A 117 TYR A 118 GLU A 120 GLU A 174 SITE 7 AC1 33 18G A 202 HOH A 341 HOH A 347 HOH A 354 SITE 8 AC1 33 HOH A 381 HOH A 397 HOH A 424 HOH A 441 SITE 9 AC1 33 HOH A 444 SITE 1 AC2 14 ILE A 9 VAL A 10 ALA A 11 MET A 25 SITE 2 AC2 14 GLU A 32 PHE A 36 THR A 58 SER A 61 SITE 3 AC2 14 PRO A 63 PHE A 66 ILE A 112 TYR A 118 SITE 4 AC2 14 NDP A 201 HOH A 340 SITE 1 AC3 6 ASN A 5 ARG A 108 VAL A 109 SER A 128 SITE 2 AC3 6 HIS A 129 PHE A 167 SITE 1 AC4 8 SER A 94 SER A 95 SER A 98 VAL A 172 SITE 2 AC4 8 HOH A 317 HOH A 336 HOH A 351 HOH A 387 SITE 1 AC5 33 VAL B 10 ALA B 11 ILE B 19 GLY B 20 SITE 2 AC5 33 GLY B 23 LYS B 24 MET B 25 GLY B 55 SITE 3 AC5 33 ARG B 56 LYS B 57 THR B 58 LEU B 77 SITE 4 AC5 33 SER B 78 ARG B 79 SER B 94 SER B 95 SITE 5 AC5 33 ILE B 96 ILE B 112 GLY B 114 ALA B 115 SITE 6 AC5 33 GLU B 116 ILE B 117 TYR B 118 GLU B 120 SITE 7 AC5 33 18G B 202 HOH B 327 HOH B 348 HOH B 358 SITE 8 AC5 33 HOH B 373 HOH B 387 HOH B 397 HOH B 409 SITE 9 AC5 33 HOH B 452 SITE 1 AC6 11 ILE B 9 VAL B 10 ALA B 11 GLU B 32 SITE 2 AC6 11 PHE B 36 THR B 58 SER B 61 PRO B 63 SITE 3 AC6 11 ILE B 112 TYR B 118 NDP B 201 SITE 1 AC7 6 LYS A 3 ASP B 105 HOH B 308 HOH B 337 SITE 2 AC7 6 HOH B 462 HOH B 469 CRYST1 38.003 66.538 75.795 90.00 93.11 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.026314 0.000000 0.001430 0.00000 SCALE2 0.000000 0.015029 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013213 0.00000 MASTER 283 0 7 14 40 0 31 6 0 0 0 30 END